Baxter International | BAX - Sales Revenues

Stock Price
17.10
Daily Change
-0.84 -4.68%
Monthly
8.23%
Yearly
-45.14%
Q2 Forecast
17.77

Baxter International reported $2.97B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Cooper Companies USD 1.02B 41.1M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
Fresenius EUR 5.88B 400M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Halozyme Therapeutics USD 451.76M 97.76M Dec/2025
ICU Medical USD 540.7M 3.7M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Laboratory Of America USD 3.52B 40M Dec/2025
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026